Detalles de la búsqueda
1.
SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation.
J Cell Mol Med
; 28(7): e18212, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38516826
2.
Molecular mechanisms on how FABP5 inhibitors promote apoptosis-induction sensitivity of prostate cancer cells.
Cell Biol Int
; 47(5): 929-942, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36651331
3.
The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis.
Biochem J
; 473(4): 449-61, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26614767
4.
FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
Int J Oncol
; 64(2)2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38131188
5.
Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use.
Am J Cancer Res
; 14(1): 300-323, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323289
6.
Fatty Acid Binding Protein 5 (FABP5) Promotes Aggressiveness of Gastric Cancer Through Modulation of Tumor Immunity.
J Gastric Cancer
; 23(2): 340-354, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129157
7.
Letter to the Editor: Perspectives on mRNA Vaccine Development for Cancer.
J Interferon Cytokine Res
; 42(11): 592-593, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112111
8.
Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
Oncotarget
; 11(31): 3025, 2020 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32821347
9.
Increased expression of Id family proteins in small cell lung cancer and its prognostic significance.
Clin Cancer Res
; 14(8): 2318-25, 2008 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18413820
10.
Fatty acid-binding protein 5 (FABP5)-related signal transduction pathway in castration-resistant prostate cancer cells: a potential therapeutic target.
Precis Clin Med
; 2(3): 192-196, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35694437
11.
Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ.
Genes Cancer
; 10(3-4): 80-96, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31258834
12.
Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression.
Int J Oncol
; 32(4): 767-75, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18360704
13.
Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer.
Hum Pathol
; 38(9): 1321-9, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17599389
14.
Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
Oncotarget
; 8(19): 31041-31056, 2017 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28415688
15.
Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.
J Natl Cancer Inst
; 94(7): 482-90, 2002 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-11929948
16.
High expression of Fatty Acid-Binding Protein 5 promotes cell growth and metastatic potential of colorectal cancer cells.
FEBS Open Bio
; 6(3): 190-9, 2016 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27047747
17.
The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance.
Oncotarget
; 7(50): 82783-82797, 2016 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27779102
18.
Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.
Oncotarget
; 7(8): 9322-39, 2016 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-26814431
19.
High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity.
Oncogene
; 22(18): 2739-49, 2003 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-12743598
20.
Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67.
Virchows Arch
; 447(4): 701-9, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16012850